Opioid Prescriber Training Program

The purpose of the New York State (NYS) Prescription Drug Overdose (PDO) Prevention Program is to advance and evaluate comprehensive state-level interventions for preventing prescription drug overuse, misuse, abuse, and overdose. Effective July 22, 2016, Public Health Law Article 33 §3309-a was updated to require prescribers with a Drug Enforcement Administration (DEA) number and medical residents prescribing under a facility DEA number to complete a minimum of three (3) hours of course work or training in pain management, palliative care and addiction. 

Included in the PDO Prevention Program objectives is an educational component for providers. The education outreach program will focus on updating providers on the Centers for Disease Control and Prevention (CDC) Guidelines for Prescribing Opioids for Chronic Pain-United States, 2016 and the topics included in the educational mandate. Part I of this educational program will provide providers with 2 hours CME at no cost to the provider. The program is supported by the Cooperative Agreement 1 NU17CE002742-01, funded by the Centers for Disease Control and Prevention (CDC) and by the NYS Department of Health.

The contents are solely the responsibility of the University at Buffalo School of Pharmacy and Pharmaceutical Sciences, and do not necessarily represent the official views of the CDC or the Department of Health and Human Services.

Target Audience

Prescribers with a DEA number and medical residents prescribing under a facility DEA number

Learning Objectives

  • Describe the pathophysiology and general approaches for pain management in the ambulatory setting.

  • Describe approaches for managing acute pain and how they would differ from approaches for managing chronic pain.

  • Outline clinical guidelines for appropriate prescribing of opioid analgesics.

  • List the federal and NYS requirements for prescribing controlled substances.

Additional Information

Partner: 
The University at Buffalo Jacobs School of Medicine
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
Course opens: 
01/28/2022
Course expires: 
07/13/2026
Rating: 
0

Part I will cover the following training areas:

  • Pain management

  • Appropriate prescribing

  • Managing acute pain

  • State and federal requirement for prescribing controlled substances

Part II will cover the following training areas:

  • Prevention, screening and signs of addiction

  • Response to abuse and addiction

  • Palliative medicine

  • End-of-life care

Speakers (Part 1)

Romanth Waghmarae, MD, DABA, FACIP, FIPP

Assistant Clinical Professor Anesthesia-McMaster UniversityRomanth

Lecturer Daemen College-PA program

Research Assistant Professor- SUNY-UB School of Pharmacy

Editorial Board AJPM, Pain Physician 

Karl D. Fiebelkorn, MBA, RPh

Senior Associate Dean

Student, Professional & Community Affairs

Associate Professor

Pharmacy Practice & Administration

UB School of Pharmacy and Pharmaceutical Sciences

Speakers (Part 2)

Richard D. Blondell, MD
University at Buffalo
Department of Family Medicine
Professor and Vice Chair for Addiction Medicine

Robert G. Wahler Jr., PharmD
Clinical Assistant Professor
Department of Pharmacy Practice
UB School of Pharmacy and Pharmaceutical Sciences
Clinical Pharmacy Services, Niagara Hospice, Inc

Program Support

The program is supported by the Cooperative Agreement 1 NU17CE002742-01, funded by the Centers for Disease Control and Prevention and by the New York State Department of Health. The contents are solely the responsibility of the University at Buffalo School of Pharmacy and Pharmaceutical Sciences, and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.

Accreditation Information:
The University at Buffalo Jacobs School of Medicine and Biomedical Sciences is accredited by the ACCME to provide continuing medical education for physicians.

Certification Information:
The University at Buffalo Jacobs School of Medicine and Biomedical Sciences designates this Enduring Material activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based enduring activity has been assigned ACPE# 0044-0000-17-004-H01-P and will award 2 contact hours (0.20 CEUs) of continuing pharmacy education credit.

Credit will be awarded to those who complete all components of this activity and achieve a successful score of 70% or greater on the post-test.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
Please login or register to take this course.

This course is offered through University at Buffalo, School of Pharmacy and Pharmaceutical Sciences. 

To take this course you will be redirected to University at Buffalo, School of Pharmacy and Pharmaceutical Sciences' website. You must login or create an account with University at Buffalo, School of Pharmacy and Pharmaceutical Sciences in order to complete this activity. 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch

Topics